Aggerbeck LP, Wetterau JR, Weisgraber KH, Mahley RW, Agard DA (1988) Crystallization and preliminary X-ray diffraction studies on the amino-terminal (receptor-binding) domain of human apolipoprotein E3 from serum very low density lipoproteins. J. Mol. Biol. 202:179–181.
Aggerbeck LP, Wetterau JR, Weisgraber KH, Wu C-SC, Lindgren FT (1988) Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. J. Biol. Chem. 263:6249–6258.
Angelin B (1988) Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in mouse peritoneal macrophages. Biochem. J. 255:529–534.
Beisiegel U, Weber W, Havinga JR, Ihrke G, Hui DY, Wernette-Hammond ME, Turck CW, Innerarity TL, Mahley RW (1988) Apolipoprotein E-binding proteins isolated from dog and human liver. Arteriosclerosis 8:288–297.
Chappell DA (1988) Pre-b-very low density lipoproteins as precursors of b-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia). J. Clin. Invest. 82:628–639.
Fainaru M, Funke H, Boyles JK, Ludwig EH, Innerarity TL, Mahley RW (1988) Metabolism of canine b-very low density lipoproteins in normal and cholesterol-fed dogs. Arteriosclerosis 8:130–139.
Fitzgerald LA, Phillips DR (1988) The molecular biology of platelet and endothelial cell adhesion receptors. In: Platelet Membrane Receptors: Molecular Biology, Immunology, Biochemistry, and Pathology (Jamieson GA, ed) Alan R. Liss, New York, pp 387–418.
Fox JEB, Aggerbeck LP, Berndt MC (1988) Structure of the glycoprotein Ib·IX complex from platelet membranes. J. Biol. Chem. 263:4882–4890.
Fox JEB, Boyles JK (1988) Characterization of the platelet membrane skeleton. In: Signal Transduction in Cytoplasmic Organization and Cell Motility (Satir P, Condeelis JS, Lazarides E, eds) Alan R. Liss, New York, pp 313–324.
Fox JEB, Boyles JK (1988) Structure and function of the platelet membrane skeleton. Soc. Gen. Physiol. Ser. 43:111–123.
Fox JEB, Boyles JK (1988) The membrane skeleton — a distinct structure that regulates the function of cells. BioEssays 8:14–18.
Fox JEB, Boyles JK, Berndt MC, Steffen PK, Anderson LK (1988) Identification of a membrane skeleton in platelets. J. Cell Biol. 106:1525–1538.
Koo C, Wernette-Hammond ME, Garcia Z, Malloy MJ, Uauy R, East C, Bilheimer DW, Mahley RW, Innerarity TL (1988) Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors. J. Clin. Invest. 81:1332–1340.
Lalazar A, Weisgraber KH, Rall SC Jr, Giladi H, Innerarity TL, Levanon AZ, Boyles JK, Amit B, Gorecki M, Mahley RW, Vogel T (1988) Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J. Biol. Chem. 263:3542–3545.
Laplaud PM, Beaubatie L, Rall SC Jr, Luc G, Saboureau M (1988) Lipoprotein[a] is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus). J. Lipid Res. 29:1157–1170.
Lauer SJ, Walker D, Elshourbagy NA, Reardon CA, Levy-Wilson B, Taylor JM (1988) Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J. Biol. Chem. 263:7277–7286.
Levy-Wilson B, Fortier C, Blackhart BD, McCarthy BJ (1988) DNase I- and micrococcal nuclease-hypersensitive sites in the human apolipoprotein B gene are tissue specific. Mol. Cell. Biol. 8:71–80.
Mahley RW (1988) Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622–630.
Mahley RW (1988) Type III hyperlipoproteinemia: Role of defective receptor binding of apolipoprotein E in the development of this lipid disorder. Ärztl. Lab. 36:60–64.
Majack RA, Castle CK, Goodman LV, Weisgraber KH, Mahley RW, Shooter EM, Gebicke-Haerter PJ (1988) Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J. Cell Biol. 107:1207–1213.
Paik Y-K, Chang DJ, Reardon CA, Walker MD, Taxman E, Taylor JM (1988) Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J. Biol. Chem. 263:13340–13349.
Phillips DR, Charo IF, Parise LV, Fitzgerald LA (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831–843.
Phillips DR, Fitzgerald LA (1988) Platelet glycoprotein IIb-IIa: Member of a family of adhesive receptor complexes. In: Biochemistry and Physiology of Platelet Membrane (Marguerie R, Zwall RFA, eds) John Libbey Eurotext, London, pp 107–120.
Reaven E, Boyles J, Spicher M, Azhar S (1988) Evidence for surface entrapment of cholesterol-rich lipoproteins in luteinized ovary. Arteriosclerosis 8:298–309.
Rodgers GM (1988) Vascular smooth muscle cells synthesize, secrete and express coagulation factor V. Biochim. Biophys. Acta 968:17–23.
Rodgers GM, Kane WH, Pitas RE (1988) Formation of Factor Va by atherosclerotic rabbit aorta mediates Factor Xa-catalyzed prothrombin activation. J. Clin. Invest. 81:1911–1919.
Weisgraber KH, Innerarity TL, Newhouse YM, Young SG, Arnold KS, Krauss RM, Vega GL, Grundy SM, Mahley RW (1988) Familial defective apolipoprotein B-100: Enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. Proc. Natl. Acad. Sci. USA 85:9758–9762.
Weisgraber KH, Newhouse YM, Mahley RW (1988) Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide probes. Biochem. Biophys. Res. Commun. 157:1212–1217.
Wetterau JR, Aggerbeck LP, Rall SC Jr, Weisgraber KH (1988) Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J. Biol. Chem. 263:6240–6248.
Young SG, Northey ST, McCarthy BJ (1988) Low plasma cholesterol levels caused by a short deletion in the apolipoprotein B gene. Science 241:591–593.
TOP
